Open an account

Defiance Daily Target 2X Long MRNA ETF

MRNX · ETF

$133.61−$5.26 (−3.79%)TodayMarket closed ·
Prev close $138.87

About MRNX

MRNX was created on 2026-02-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. MRNX seeks to deliver 2x leveraged exposure to the daily share price movement of Moderna, Inc. (NASDAQ: MRNA), net fees and expenses, through derivatives like swap agreements. MRNA develops mRNA-based vaccines and therapies, best known for its COVID-19 vaccine.

Issuer
Defiance
Expense ratio
1.34%
Assets under management
$93.78M
Inception
Feb 3, 2026
Asset class
Equity
Website
defianceetfs.com

MRNX key statistics

Price-earnings ratio
0.00
Average volume
285.37K
Volume
421.82K
Open price
$128.67
High today
$143.29
Low today
$110.42
52 Week high
$227.90
52 Week low
$14.95

Defiance Daily Target 2X Long MRNA ETF (MRNX) at a glance

Defiance Daily Target 2X Long MRNA ETF (MRNX) last traded at $133.61, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $110.42 and $143.29. The current price is 21.0% above the day's low and 6.8% below its high.

Volume so far is 421.82K shares, above the average of 285.37K shares a day.

Over the past year Defiance Daily Target 2X Long MRNA ETF has ranged from $14.95 to $227.90, and now sits 56% of the way up that range.

MRNX news

  • Chandrima Sanyal

    Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.